Continuous glucose monitoring in very preterm infants shows low ketones and higher lactate in first week
This prespecified substudy of an RCT analyzed 168 very low birth weight infants (85 females) in an international multicentre setting. The intervention was continuous glucose monitoring in glycaemic care from the REACT trial; the comparator for this substudy was not reported in the abstract. The primary outcome was ketone and lactate concentrations in the first week of life.
Lactate concentrations were higher initially and lowered over time, with a mean (SD) of 1.72 (1.26) mmol/L on day 2 and 1.19 (1.1) mmol/L on day 7. Ketone concentrations were consistently low at 0.1 mmol/L. Relationships with blood glucose, macronutrient intake, and insulin treatment were not consistently related to ketone or lactate concentrations.
Safety and tolerability were not reported; no adverse events, serious adverse events, or discontinuations were described. Key limitations include that the abstract does not report comparator details for the substudy, no p-values or confidence intervals are provided, and findings are limited to the first week of life.
Practice relevance highlights persistently low ketones and relatively higher lactate in very preterm infants, suggesting a need for future research on metabolites during hypoglycaemia or hyperglycaemia. Causality cannot be inferred from this observational substudy of an RCT.